Skeletal Muscle Dysfunction in Idiopathic Pulmonary Arterial Hypertension

Autor: John Granton, Jane Batt, Alexandra Bain, Samar Shadly Ahmed, Judy Correa
Rok vydání: 2014
Předmět:
Adult
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Vastus lateralis muscle
Hypertension
Pulmonary

Ubiquitin-Protein Ligases
Clinical Biochemistry
Muscle Proteins
Motor Activity
Biology
Mitochondrion
Mitochondrial Membrane Transport Proteins
GTP Phosphohydrolases
Quadriceps Muscle
Muscle hypertrophy
Mitochondrial Proteins
Tripartite Motif Proteins
Internal medicine
medicine
Humans
Familial Primary Pulmonary Hypertension
Phosphorylation
Exercise
Molecular Biology
SKP Cullin F-Box Protein Ligases
Ryanodine receptor
Ribosomal Protein S6 Kinases
70-kDa

Skeletal muscle
Ryanodine Receptor Calcium Release Channel
Mitochondrial Turnover
Cell Biology
Anatomy
Muscle atrophy
Mitochondria
Muscular Atrophy
medicine.anatomical_structure
Endocrinology
Mitochondrial biogenesis
Muscle Fibers
Fast-Twitch

Quality of Life
Female
medicine.symptom
Proto-Oncogene Proteins c-akt
Anaerobic exercise
Signal Transduction
Zdroj: American Journal of Respiratory Cell and Molecular Biology. 50:74-86
ISSN: 1535-4989
1044-1549
Popis: Despite improvements in survival with disease-targeted therapies, the majority of patients with pulmonary arterial hypertension (PAH) have persistent exercise intolerance that results from impaired cardiac function and skeletal muscle dysfunction. Our intent was to understand the molecular mechanisms mediating skeletal muscle dysfunction in PAH. A total of 12 patients with PAH and 10 matched control subjects were assessed. Patients with PAH demonstrated diminished exercise capacity (lower oxygen uptake max, lower anaerobic threshold and higher minute ventilation/CO2) compared with control subjects. Quadriceps muscle cross-sectional area was significantly smaller in patients with PAH. The vastus lateralis muscle was biopsied to enable muscle fiber morphometric assessment and to determine expression levels/activation of proteins regulating (1) muscle mass, (2) mitochondria biogenesis and shaping machinery, and (3) excitation-contraction coupling. Patients with PAH demonstrated a decreased type I/type II muscle fiber ratio, with a smaller cross-sectional area in the type I fibers. Diminished AKT and p70S6 kinase phosphorylation, with increased atrogin-1 and muscle RING-finger protein-1 transcript levels, were evident in the PAH muscle, suggesting engagement of cellular signaling networks stimulating ubiquitin-proteasome-mediated proteolysis of muscle, with concurrent depression of networks mediating muscle hypertrophy. Although there were no differences in expression/activation of proteins associated with mitochondrial biogenesis or fission (MTCO2 [cytochrome C oxidase subunit II]/succinate dehydrogenase flavoprotein subunit A, mitochondrial transcription factor A, nuclear respiratory factor-1/dynamin-related protein 1 phosphorylation), protein levels of a positive regulator of mitochondrial fusion, Mitofusin2, were significantly lower in patients with PAH. Patients with PAH demonstrated increased phosphorylation of ryanodine receptor 1 receptors, suggesting that altered sarcoplasmic reticulum Ca(++) sequestration may impair excitation-contraction coupling in the PAH muscle. These data suggest that muscle dysfunction in PAH results from a combination of muscle atrophy and intrinsically impaired contractility.
Databáze: OpenAIRE